624 related articles for article (PubMed ID: 19614557)
21. Fungal colonization of the respiratory tract in allogeneic and autologous hematopoietic stem cell transplant recipients: a study of 573 transplanted patients.
Markowski J; Helbig G; Widziszowska A; Likus W; Kyrcz-Krzemień S; Jarosz U; Dziubdziela W; Markiewicz M
Med Sci Monit; 2015 Apr; 21():1173-80. PubMed ID: 25907308
[TBL] [Abstract][Full Text] [Related]
22. Factors influencing the performance level of Candida mannan antigen testing in allogeneic stem cell transplant recipients not receiving fluconazole prophylaxis.
Nihtinen A; Anttila VJ; Richardson M; Ruutu T; Juvonen E; Meri T; Volin L
Transpl Infect Dis; 2011 Jun; 13(3):266-72. PubMed ID: 21176021
[TBL] [Abstract][Full Text] [Related]
23. Role of the mycobiome in human acute graft-versus-host disease.
van der Velden WJ; Netea MG; de Haan AF; Huls GA; Donnelly JP; Blijlevens NM
Biol Blood Marrow Transplant; 2013 Feb; 19(2):329-32. PubMed ID: 23160005
[TBL] [Abstract][Full Text] [Related]
24. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).
Leroy O; Gangneux JP; Montravers P; Mira JP; Gouin F; Sollet JP; Carlet J; Reynes J; Rosenheim M; Regnier B; Lortholary O;
Crit Care Med; 2009 May; 37(5):1612-8. PubMed ID: 19325476
[TBL] [Abstract][Full Text] [Related]
25. The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy.
Hachem R; Hanna H; Kontoyiannis D; Jiang Y; Raad I
Cancer; 2008 Jun; 112(11):2493-9. PubMed ID: 18412153
[TBL] [Abstract][Full Text] [Related]
26. Spectrum and risk factors for invasive candidiasis and non-Candida fungal infections after liver transplantation.
Shi SH; Lu AW; Shen Y; Jia CK; Wang WL; Xie HY; Zhang M; Liang TB; Zheng SS
Chin Med J (Engl); 2008 Apr; 121(7):625-30. PubMed ID: 18466683
[TBL] [Abstract][Full Text] [Related]
27. Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001-2007): stable incidence but changing epidemiology of a still frequently lethal infection.
Sipsas NV; Lewis RE; Tarrand J; Hachem R; Rolston KV; Raad II; Kontoyiannis DP
Cancer; 2009 Oct; 115(20):4745-52. PubMed ID: 19634156
[TBL] [Abstract][Full Text] [Related]
28. New strategies of antifungal therapy in hematopoietic stem cell transplant recipients and patients with hematological malignancies.
Leather HL; Wingard JR
Blood Rev; 2006 Sep; 20(5):267-87. PubMed ID: 16781028
[TBL] [Abstract][Full Text] [Related]
29. Candida krusei sepsis secondary to oral colonization in a hemopoietic stem cell transplant recipient.
Westbrook SD; Kirkpatrick WR; Freytes CO; Toro JJ; Bernardo S; Patterson TF; Redding SW; Lee SA
Med Mycol; 2007 Mar; 45(2):187-90. PubMed ID: 17365656
[TBL] [Abstract][Full Text] [Related]
30. Candida colonization and candidemia in a pediatric intensive care unit.
Singhi S; Rao DS; Chakrabarti A
Pediatr Crit Care Med; 2008 Jan; 9(1):91-5. PubMed ID: 18477920
[TBL] [Abstract][Full Text] [Related]
31. Candidemia in nonneutropenic critically ill patients: risk factors for non-albicans Candida spp.
Playford EG; Marriott D; Nguyen Q; Chen S; Ellis D; Slavin M; Sorrell TC
Crit Care Med; 2008 Jul; 36(7):2034-9. PubMed ID: 18552700
[TBL] [Abstract][Full Text] [Related]
32. [Cost benefit analysis for prophylactic use of itraconazole versus fluconazole after hematopoietic stem cell transplantation].
Ota S; Wada A; Kosugi M; Matsuoka S; Asanuma S; Fujii S; Noguchi S; Nakata M; Imai K; Hirano T; Kobayashi N; Ogasawara M; Kiyama Y; Kasai M
Rinsho Ketsueki; 2010 Jan; 51(1):63-8. PubMed ID: 20134142
[TBL] [Abstract][Full Text] [Related]
33. Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole.
Marr KA; Seidel K; White TC; Bowden RA
J Infect Dis; 2000 Jan; 181(1):309-16. PubMed ID: 10608780
[TBL] [Abstract][Full Text] [Related]
34. Presumptive treatment strategy for aspergillosis in allogeneic haematopoietic stem cell transplant recipients.
Oshima K; Kanda Y; Asano-Mori Y; Nishimoto N; Arai S; Nagai S; Sato H; Watanabe T; Hosoya N; Izutsu K; Asai T; Hangaishi A; Motokura T; Chiba S; Kurokawa M
J Antimicrob Chemother; 2007 Aug; 60(2):350-5. PubMed ID: 17584800
[TBL] [Abstract][Full Text] [Related]
35. Routine use of fluconazole prophylaxis in a neonatal intensive care unit does not select natively fluconazole-resistant Candida subspecies.
Manzoni P; Leonessa M; Galletto P; Latino MA; Arisio R; Maule M; Agriesti G; Gastaldo L; Gallo E; Mostert M; Farina D
Pediatr Infect Dis J; 2008 Aug; 27(8):731-7. PubMed ID: 18600191
[TBL] [Abstract][Full Text] [Related]
36. Recent advances in antifungal prevention and treatment.
Groll AH; Tragiannidis A
Semin Hematol; 2009 Jul; 46(3):212-29. PubMed ID: 19549575
[TBL] [Abstract][Full Text] [Related]
37. Oral candidiasis in immunosuppressed children and young adults after liver or kidney transplantation.
Olczak-Kowalczyk D; Pawłowska J; Garczewska B; Smirska E; Grenda R; Syczewska M; Kowalczyk W
Pediatr Dent; 2010; 32(3):189-94. PubMed ID: 20557701
[TBL] [Abstract][Full Text] [Related]
38. Trends in invasive disease due to Candida species following heart and lung transplantation.
Schaenman JM; Rosso F; Austin JM; Baron EJ; Gamberg P; Miller J; Oyer PE; Robbins RC; Montoya JG
Transpl Infect Dis; 2009 Apr; 11(2):112-21. PubMed ID: 19254327
[TBL] [Abstract][Full Text] [Related]
39. Initial treatment and outcome of Candida glabrata versus Candida albicans bloodstream infection.
Klevay MJ; Horn DL; Neofytos D; Pfaller MA; Diekema DJ;
Diagn Microbiol Infect Dis; 2009 Jun; 64(2):152-7. PubMed ID: 19376667
[TBL] [Abstract][Full Text] [Related]
40. Patterns of fungal colonization in preterm infants weighing less than 1000 grams at birth.
Kaufman DA; Gurka MJ; Hazen KC; Boyle R; Robinson M; Grossman LB
Pediatr Infect Dis J; 2006 Aug; 25(8):733-7. PubMed ID: 16874174
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]